Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EK.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EK.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EF.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EF.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BU.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BU.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BU.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BU.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
BA.5.1.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CJ.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CJ.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CJ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.6.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.7.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used